Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

Table 1 Accessibility of the models

	GSK	Harvard	Merck	South African	Thai	WHO-CHOICE
Complexity of evaluation for this exercise:
System used	Desktop PC	Linux cluster	Desktop PC	Desktop PC	Desktop PC	Desktop PC
Coding platform	Excel	C++	Mathematica	TreeAge	Excel VBA	Excel VBA
Time taken (person h)	30	15	20	12	25	32
Availability to new users:
Source code	X					X
Front end	X		X (web based)		X	X
Documentation	X		X		X
Availability	1	3	2	3	2	1

Accessibility of the models in terms of their complexity (based on the evaluation conducted for this exercise) and availability to new users. Availability of the model to new users is rated according to the following: (1) freely available for anyone to use, (2) may be available as part of collaboration under supervision by developers, (3) may be available to apply to new settings provided the evaluation is conducted by developers.
WHO-CHOICE = World Health Organization 'CHOosing Interventions that are Cost Effective' model; VBA = visual basic application.

ISSN: 1741-7015